Impaired HDL function and endothelial barrier stability in severe anaphylaxis.

Autor: Fernandez-Bravo S; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain., Canyelles M; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain., Martín-Blázquez A; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain., Borràs C; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain., Nuñez-Borque E; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain., Palacio-García L; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain., Rodríguez Del Rio P; Allergy Department, Hospital Infantil Universitario Niño Jesús, Fundación HNJ, Health Research Institute-Princesa, Madrid, Spain., Betancor D; Department of Allergy. Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (FJD, UAM), 28040 Madrid, Spain., Gómez-López A; Department of Allergy. Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (FJD, UAM), 28040 Madrid, Spain., Sabaté Brescó M; Department of Allergy and Clinic Immunology, Clínica Universidad de Navarra, Pamplona, Spain, Red de Enfermedades Inflamatorias (RD21/0002/0028); Health Research Institute (IDISNA, Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain., Laguna JJ; Allergy Unit, Allergo-Anaesthesia Unit, Cruz Roja Central Hospital, Madrid, Spain, Red de Enfermedades Inflamatorias (RD21/0002/0008)., Méndez-Barbero N; Vascular Pathology Research Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain. CIBERCV; Faculty of Medicine, Universidad Alfonso X el Sabio (UAX), Villanueva de la Cañada, Spain., Rotllan N; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain., Escolà-Gil JC; Institut de Recerca de l'Hospital Santa Creu i Sant Pau, Institut d'Investigacions Biomèdiques Sant Pau, Barcelona, Spain; CIBER of Diabetes and Related Metabolic Diseases, Instituto de Salud Carlos III, Madrid, Spain., Esteban V; Department of Allergy and Immunology, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain; Faculty of Medicine, Universidad Alfonso X el Sabio (UAX), Villanueva de la Cañada, Spain. Electronic address: vesteban@fjd.es.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 May 06. Date of Electronic Publication: 2024 May 06.

The impact of type 2 immunity and allergic diseases in atherosclerosis.

Autor: Fernández-Gallego N; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain., Castillo-González R; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Department of Pathology, Hospital 12 de Octubre, Madrid, Spain., Méndez-Barbero N; Vascular Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., López-Sanz C; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain., Obeso D; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Chemistry and Biochemistry, Faculty of Pharmacy, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Villaseñor A; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.; Department of Chemistry and Biochemistry, Faculty of Pharmacy, Centre for Metabolomics and Bioanalysis (CEMBIO), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Escribese MM; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., López-Melgar B; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Salamanca J; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Benedicto-Buendía A; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Jiménez-Borreguero LJ; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.; Department of Cardiology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Ibañez B; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.; Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Cardiology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Sastre J; Department of Allergy and Immunology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Belver MT; Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Vega F; Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Blanco C; Department of Allergy, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain., Barber D; Department of Basic Medical Sciences, Faculty of Medicine, Institute of Applied Molecular Medicine Nemesio Díez (IMMA), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Sánchez-Madrid F; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., de la Fuente H; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Martín P; Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Esteban V; Department of Allergy and Immunology, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Faculty of Medicine and Biomedicine, Universidad Alfonso X El Sabio, Madrid, Spain., Jiménez-Saiz R; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB)-CSIC, Madrid, Spain.; Faculty of Experimental Sciences, Universidad Francisco de Vitoria (UFV), Madrid, Spain.; Department of Medicine, McMaster Immunology Research Centre (MIRC), McMaster University, Hamilton, Ontario, Canada.

Publikováno v: Allergy [Allergy] 2022 Nov; Vol. 77 (11), pp. 3249-3266. Date of Electronic Publication: 2022 Jul 18.

Annexins and cardiovascular diseases: Beyond membrane trafficking and repair.

Autor: Méndez-Barbero N; Laboratory of Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBERCV, Madrid, Spain., San Sebastian-Jaraba I; Laboratory of Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBERCV, Madrid, Spain., Blázquez-Serra R; Laboratory of Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBERCV, Madrid, Spain., Martín-Ventura JL; Laboratory of Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBERCV, Madrid, Spain.; Autonoma University of Madrid, Madrid, Spain., Blanco-Colio LM; Laboratory of Vascular Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBERCV, Madrid, Spain.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Oct 14; Vol. 10, pp. 1000760. Date of Electronic Publication: 2022 Oct 14 (Print Publication: 2022).

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

Autor: Montero, R.R., Perez-Saez, J.M., Cerro-Pardo, I., Martinez-Lopez, D., Nuñez, E., Maller, S., Gutierrez-Muñoz, C., Mendez-Barbero, N., Escola-Gil, J.C., Michel, J.B., Vazquez, J., Blanco-Colio, L.M., Rabinovich, G.A., Martin-Ventura, J.L.

Publikováno v: In Atherosclerosis August 2021 331:e96-e97

Annexins: Involvement in cholesterol homeostasis, inflammatory response and atherosclerosis.

Autor: Méndez-Barbero N; Laboratorio de Patología Vascular, IIS-Fundación Jiménez Díaz, Madrid, España; CIBER de Enfermedades Cardiovasculares (CIBERCV), España., Gutiérrez-Muñoz C; Laboratorio de Patología Vascular, IIS-Fundación Jiménez Díaz, Madrid, España; CIBER de Enfermedades Cardiovasculares (CIBERCV), España., Blázquez-Serra R; CIBER de Enfermedades Cardiovasculares (CIBERCV), España., Martín-Ventura JL; Laboratorio de Patología Vascular, IIS-Fundación Jiménez Díaz, Madrid, España; CIBER de Enfermedades Cardiovasculares (CIBERCV), España., Blanco-Colio LM; Laboratorio de Patología Vascular, IIS-Fundación Jiménez Díaz, Madrid, España; CIBER de Enfermedades Cardiovasculares (CIBERCV), España. Electronic address: lblanco@fjd.es.

Publikováno v: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis [Clin Investig Arterioscler] 2021 Jul-Aug; Vol. 33 (4), pp. 206-216. Date of Electronic Publication: 2021 Feb 20.